Accuray Incorporated 2026 Q4 - Results - Earnings Call Presentation
2026-08-20. The following slide deck was published by Accuray Incorporated in conjunction with their 2026 Q4 earnings call.
SeekingAlpha15 days agoARAY
Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Accuray Incorporated (ARAY) Q4 2026 Earnings Call August 19, 2026 4:30 PM EDTCompany ParticipantsStephen Monroe - Vice President of Financial Planning &...
SeekingAlpha15 days agoARAY
Accuray Q4 2026 Earnings Call: Complete Transcript
Accuray (NASDAQ:ARAY) released fourth-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
Benzinga16 days agoARAY
Accuray Says Not Providing Formal Revenue Or Adjusted EBITDA Guidance For Fiscal 2027 At This Time
Fiscal Year 2027 Financial GuidanceAs the Company enters fiscal 2027, management believes Accuray is operating from a position of greater strength than a year ago. The Company expects continued growth in service
Benzinga16 days agoARAY
Accuray Q4 EPS $(0.02) Beats $(0.10) Estimate, Sales $100.919M Miss $105.300M Estimate
Accuray (NASDAQ:ARAY) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.10) by 80 percent. This is a 300 percent decrease over earnings of $0.01 per share from the same
Benzinga16 days agoARAY
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2 earnings report
Benzinga24 days agoARAY